Ondansetron for tardive dyskinesia

Am J Psychiatry. 2001 Apr;158(4):657-8. doi: 10.1176/appi.ajp.158.4.657-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Benzodiazepines
  • Clozapine / adverse effects
  • Clozapine / pharmacokinetics
  • Clozapine / therapeutic use
  • Drug Interactions
  • Dyskinesia, Drug-Induced / drug therapy*
  • Dyskinesia, Drug-Induced / etiology*
  • Humans
  • Olanzapine
  • Ondansetron / pharmacokinetics
  • Ondansetron / therapeutic use*
  • Pirenzepine / adverse effects
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / pharmacokinetics
  • Pirenzepine / therapeutic use
  • Receptors, Serotonin / drug effects
  • Serotonin Antagonists / pharmacokinetics
  • Serotonin Antagonists / therapeutic use*

Substances

  • Antipsychotic Agents
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Benzodiazepines
  • Pirenzepine
  • Ondansetron
  • Clozapine
  • Olanzapine